Compare Borosil Scienti. with Similar Stocks
Dashboard
Poor Management Efficiency with a low ROE of 4.53%
- The company has been able to generate a Return on Equity (avg) of 4.53% signifying low profitability per unit of shareholders funds
Poor long term growth as Net Sales has grown by an annual rate of 9.80% and Operating profit at 2.86% over the last 5 years
With ROE of 4.5, it has a Expensive valuation with a 2.5 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0.04% of the company
Stock DNA
Industrial Products
INR 963 Cr (Micro Cap)
41.00
44
0.00%
-0.27
4.53%
2.43
Total Returns (Price + Dividend) 
Borosil Scienti. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Borosil Scientific Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
Borosil Scientific Ltd has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish stance, as reflected in recent market data and technical indicators. Despite a strong day change of 7.18%, the stock’s overall technical profile remains mixed, with some bullish signals emerging alongside persistent bearish trends. This analysis delves into the key technical parameters shaping investor sentiment and the stock’s near-term outlook.
Read full news article
Borosil Scientific Ltd is Rated Sell
Borosil Scientific Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trend, and technical outlook.
Read full news article Announcements 
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
01-Apr-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shreevar Kheruka
Closure of Trading Window
26-Mar-2026 | Source : BSEClosure of Trading Window
Announcement under Regulation 30 (LODR)-Investor Presentation
13-Feb-2026 | Source : BSEInvestor presentation for unaudited financial results for quarter and nine months ended December 31 2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 18 FIIs (0.07%)
Kiran Kheruka (25.52%)
Borosil Scientific Limited Unclaimed Securities Suspense Escrow Account (2.2%)
23.06%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 13.47% vs 11.38% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 200.35% vs 169.47% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -1.90% vs 15.21% in Sep 2024
Growth in half year ended Sep 2025 is -109.18% vs 62.32% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 5.16% vs 10.41% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -59.13% vs 27.14% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 10.51% vs 9.00% in Mar 2024
YoY Growth in year ended Mar 2025 is 11.32% vs 3.25% in Mar 2024







